-
Posted by
Two Blokes Jul 19 -
Filed in
Stock
-
6 views
Q2 results show stabilization but nowhere near enough momentum for a Buy; macro risks and regional weakness persist, especially in Northern Europe. Management's cost discipline is encouraging, but I remain on Hold until I see sustained growth in Experis and margin recovery in Europe. Valuation appears undemanding, but low multiples reflect justified market caution; stock may stay depressed if trends don't improve.
